Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women.

164 Background: TRAP laws impose unnecessary rules on abortion providers, hindering care like cancer screening for low-income women. This study examines TRAP laws' impact on breast and cervical cancer screening (BCS and CCS) rates in this group. Methods: We identified low-income women (≤$35,000 annual income) from the 2012-2018 Behavioral Risk Factor Surveillance System survey. States were grouped by TRAP law status: 1) existing, 2) new in 2017, 3) without. Outcomes were self-reported BCS via mammography for women aged 40 and above, and CCS via Pap test for women aged 21-65 without a history of hysterectomy, in the past year. Multivariate logistic regression estimated adjusted screening prevalence (aSP) and adjusted prevalence ratios (aPR), comparing 2012-2016 and 2018 screening rates by TRAP law. We also performed difference-in-difference (DiD) analysis on screening rates in TRAP vs. non-TRAP states between 2012-2016 and 2018. Results: From 2012 to 2016, BCS and CCS prevalence rates were similar between states with TRAP laws (BCS: 56.44%, CCS: 54.26%) and those without (BCS: 56.77%, CCS: 54.12%), with aPR of 1.08 for BCS and 0.91 for CCS. In 2018, BCS rates increased in states with existing TRAP laws (56.44% to 56.98%) but decreased in states with new TRAP laws (56.96% to 55.02%) and states without TRAP laws (56.77% to 54.36%). The aPR for BCS and CCS in states with new 2017 TRAP laws were 0.95 and 1.04, while states without TRAP laws had aPRs of 0.93 for BCS and 0.88 for CCS. All results were statistically significant at alpha = 0.05. The DiD analysis indicated a significant BCS increase in TRAP states compared to non-TRAP states from 2012-2016 to 2018, with a DID estimate of 0.0288 (p-value <0.001). The DID estimate for CCS was 0.0158 (p-value 0.126), indicating no significant change. Conclusions: Overall, BCS rates increased in states with longstanding TRAP laws but decreased in states with new or no TRAP laws, suggesting a positive association between TRAP laws and BCS. However, no significant impact was observed for CCS, highlighting a more definite effect of TRAP laws on BCS among low-income women. Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women. aSP* aPR* 2012-2016 2018 2012-2016 vs 2018 States with existing TRAP law Breast 56.44% 56.98% 1.08 Cervical 54.26% 48.44% 0.91 States with new TRAP law in 2017 Breast 56.96% 55.02% 0.95 Cervical 54.79% 56.51% 1.04 States without TRAP laws Breast 56.77% 54.36% 0.93 Cervical 54.12% 50.89% 0.88 Models adjusted for age, race, body mass index, marital status, education, insurance status, general health status, state, and year. *All results were statistically significant at alpha = 0.05.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-10-01
DOI
https://doi.org/10.1200/op.2025.21.10_suppl.164
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women.

K. Robin Yabroff, Priti Bandi, Jessica Star, Xuesong Han et al.
JCO Oncology Practice
Cervical Cancer and HPV Research
article

Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women.

K. Robin Yabroff, Priti Bandi, Jessica Star, Xuesong Han, Margaret Katana Ogongo
article en

Abstract

164 Background: TRAP laws impose unnecessary rules on abortion providers, hindering care like cancer screening for low-income women. This study examines TRAP laws' impact on breast and cervical cancer screening (BCS and CCS) rates in this group. Methods: We identified low-income women (≤$35,000 annual income) from the 2012-2018 Behavioral Risk Factor Surveillance System survey. States were grouped by TRAP law status: 1) existing, 2) new in 2017, 3) without. Outcomes were self-reported BCS via mammography for women aged 40 and above, and CCS via Pap test for women aged 21-65 without a history of hysterectomy, in the past year. Multivariate logistic regression estimated adjusted screening prevalence (aSP) and adjusted prevalence ratios (aPR), comparing 2012-2016 and 2018 screening rates by TRAP law. We also performed difference-in-difference (DiD) analysis on screening rates in TRAP vs. non-TRAP states between 2012-2016 and 2018. Results: From 2012 to 2016, BCS and CCS prevalence rates were similar between states with TRAP laws (BCS: 56.44%, CCS: 54.26%) and those without (BCS: 56.77%, CCS: 54.12%), with aPR of 1.08 for BCS and 0.91 for CCS. In 2018, BCS rates increased in states with existing TRAP laws (56.44% to 56.98%) but decreased in states with new TRAP laws (56.96% to 55.02%) and states without TRAP laws (56.77% to 54.36%). The aPR for BCS and CCS in states with new 2017 TRAP laws were 0.95 and 1.04, while states without TRAP laws had aPRs of 0.93 for BCS and 0.88 for CCS. All results were statistically significant at alpha = 0.05. The DiD analysis indicated a significant BCS increase in TRAP states compared to non-TRAP states from 2012-2016 to 2018, with a DID estimate of 0.0288 (p-value <0.001). The DID estimate for CCS was 0.0158 (p-value 0.126), indicating no significant change. Conclusions: Overall, BCS rates increased in states with longstanding TRAP laws but decreased in states with new or no TRAP laws, suggesting a positive association between TRAP laws and BCS. However, no significant impact was observed for CCS, highlighting a more definite effect of TRAP laws on BCS among low-income women. Targeted restriction on abortion provider (TRAP) laws and breast and cervical cancer screening in low-income women. aSP* aPR* 2012-2016 2018 2012-2016 vs 2018 States with existing TRAP law Breast 56.44% 56.98% 1.08 Cervical 54.26% 48.44% 0.91 States with new TRAP law in 2017 Breast 56.96% 55.02% 0.95 Cervical 54.79% 56.51% 1.04 States without TRAP laws Breast 56.77% 54.36% 0.93 Cervical 54.12% 50.89% 0.88 Models adjusted for age, race, body mass index, marital status, education, insurance status, general health status, state, and year. *All results were statistically significant at alpha = 0.05.

JCO Oncology PracticeVol. 21(10_suppl)
American Cancer Society (US)
Openalex Percentile: Top 62%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.